Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

47.07
Delayed Data
As of Jul 21
 -0.72 / -1.51%
Today’s Change
37.35
Today|||52-Week Range
55.38
+21.63%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Obrien Christopher Flint
Chief Medical Officer
Sale5/18/2017105,634$53.32$5.6M-12.15%
Obrien Christopher Flint
Chief Medical Officer
Sale11/15/201625,000$52.84$1.3M-11.07%
Gorman Kevin Charles
Chief Executive Officer
Sale5/02/201721,739$53.23$1.2M-12.56%
Gorman Kevin Charles
Chief Executive Officer
Sale4/12/201719,290$50.41$972.4K-9.13%
Gano Kyle
Chief Business Development Officer
Sale5/01/201715,000$54.00$810.0K-13.87%
Bozigian Haig P
Chief Development Officer
Sale4/12/201712,861$50.41$648.3K-9.13%
Gano Kyle
Chief Business Development Officer
Sale4/12/201712,861$50.41$648.3K-9.13%
Grigoriadis Dimitri E
Chief Research Officer
Sale4/12/201712,861$50.41$648.3K-9.13%
Lippoldt Darin M
Chief Legal Officer
Sale4/12/201712,861$50.41$648.3K-9.13%
Lloyd Smith Malcolm
Chief Regulatory Officer
Sale4/12/201712,861$50.41$648.3K-9.13%
Page of 8